Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone

V. Conteduca; O. Caffo; C. Lolli; M. Aieta; E. Scarpi; E. Bianchi; F. Maines; G. Schepisi; S. Salvi; F. Massari; F. Carrozza; A. Veccia; V.E. Chiuri; E. Campadelli; G. Facchini; U. De Giorgi

doi:10.1002/pros.23357

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone

V. Conteduca, O. Caffo, C. Lolli, M. Aieta, E. Scarpi, E. Bianchi, F. Maines, G. Schepisi, S. Salvi, F. Massari, F. Carrozza, A. Veccia, V.E. Chiuri, E. Campadelli, G. Facchini, U. De Giorgi

Research output: Contribution to journal › Article › peer-review

Original language	Italian
Pages (from-to)	1012-1019
Number of pages	8
Journal	Prostate
Volume	77
Issue number	9
DOIs	https://doi.org/10.1002/pros.23357
Publication status	Published - 2017

Access to Document

10.1002/pros.23357

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018635498&doi=10.1002%2fpros.23357&partnerID=40&md5=161b8e7869aecb0d4f65ac4abe1ee2e8

Cite this

Conteduca, V., Caffo, O., Lolli, C., Aieta, M., Scarpi, E., Bianchi, E., Maines, F., Schepisi, G., Salvi, S., Massari, F., Carrozza, F., Veccia, A., Chiuri, V. E., Campadelli, E., Facchini, G., & De Giorgi, U. (2017). Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone. Prostate, 77(9), 1012-1019. https://doi.org/10.1002/pros.23357

Conteduca, V, Caffo, O, Lolli, C , Aieta, M , Scarpi, E, Bianchi, E, Maines, F, Schepisi, G, Salvi, S, Massari, F, Carrozza, F, Veccia, A, Chiuri, VE, Campadelli, E, Facchini, G & De Giorgi, U 2017, 'Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone', Prostate, vol. 77, no. 9, pp. 1012-1019. https://doi.org/10.1002/pros.23357

@article{6a8a8a8b3171449496985c0062a9f740,

title = "Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone",

author = "V. Conteduca and O. Caffo and C. Lolli and M. Aieta and E. Scarpi and E. Bianchi and F. Maines and G. Schepisi and S. Salvi and F. Massari and F. Carrozza and A. Veccia and V.E. Chiuri and E. Campadelli and G. Facchini and {De Giorgi}, U.",

note = "Cited By :2 Export Date: 8 February 2018",

year = "2017",

doi = "10.1002/pros.23357",

language = "Italian",

volume = "77",

pages = "1012--1019",

journal = "Prostate",

issn = "0270-4137",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone

AU - Conteduca, V.

AU - Caffo, O.

AU - Lolli, C.

AU - Aieta, M.

AU - Scarpi, E.

AU - Bianchi, E.

AU - Maines, F.

AU - Schepisi, G.

AU - Salvi, S.

AU - Massari, F.

AU - Carrozza, F.

AU - Veccia, A.

AU - Chiuri, V.E.

AU - Campadelli, E.

AU - Facchini, G.

AU - De Giorgi, U.

N1 - Cited By :2 Export Date: 8 February 2018

PY - 2017

Y1 - 2017

U2 - 10.1002/pros.23357

DO - 10.1002/pros.23357

M3 - Articolo

VL - 77

SP - 1012

EP - 1019

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 9

ER -